Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer
- PMID: 15838173
- DOI: 10.1159/000085347
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer
Abstract
Background: Positron emission tomography (PET) has been proposed for pancreatic cancer diagnosis and staging.
Methods: 112 patients with suspected pancreatic cancer underwent 18F-fluoro-2-deoxy-D-glucose gamma camera PET and computed tomography (CT), of whom 62 also had laparoscopic ultrasonography and 70 underwent abdominal exploration for potential resection. The final diagnosis was malignancy in 78 and benign disease in 34 patients (25 with chronic pancreatitis).
Results: The diagnostic sensitivity and specificity for PET were 73 and 60% compared to 89 and 65% for CT respectively (Cohen's kappa = 0.59). In 30 patients CT was equivocal with cancer in 14 and benign disease in 16. PET correctly diagnosed 13 of these patients (cancer in 6 and benign disease in 7), interpreted 4 as equivocal (cancer in 3 and benign disease in 1) but was incorrect in the remaining 13 patients (cancer in 5 and benign disease in 8). The sensitivity and specificity for detecting small volume metastatic disease were 20 and 94% for CT and 22 and 91% for PET, respectively.
Conclusion: PET had a similar accuracy to that of CT for imaging pancreatic cancer but it did not provide any additional information in patients with equivocal CT findings and currently would seem of little benefit for the staging of pancreatic cancer.
Comment in
-
18-fluorodeoxyglucose positron emission tomography and pancreatic cancer.Dig Surg. 2005;22(6):467-8; author reply 468-9. doi: 10.1159/000092036. Epub 2006 Mar 16. Dig Surg. 2005. PMID: 16549928 No abstract available.
Similar articles
-
The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.J Clin Gastroenterol. 2006 Nov-Dec;40(10):923-9. doi: 10.1097/01.mcg.0000225672.68852.05. J Clin Gastroenterol. 2006. PMID: 17063113
-
The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.Pancreas. 2012 Aug;41(6):897-903. doi: 10.1097/MPA.0b013e318252f4f5. Pancreas. 2012. PMID: 22699202
-
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.Health Technol Assess. 2018 Feb;22(7):1-114. doi: 10.3310/hta22070. Health Technol Assess. 2018. PMID: 29402376 Free PMC article.
-
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464906 Review.
-
The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.Abdom Radiol (NY). 2018 Feb;43(2):415-434. doi: 10.1007/s00261-017-1374-2. Abdom Radiol (NY). 2018. PMID: 29143875 Review.
Cited by
-
Endoscopic ultrasonography for pancreatic cancer: current and future perspectives.J Gastrointest Oncol. 2013 Jun;4(2):220-30. doi: 10.3978/j.issn.2078-6891.2013.002. J Gastrointest Oncol. 2013. PMID: 23730519 Free PMC article.
-
Electrochemical Biosensors for Detection of MicroRNA as a Cancer Biomarker: Pros and Cons.Biosensors (Basel). 2020 Nov 20;10(11):186. doi: 10.3390/bios10110186. Biosensors (Basel). 2020. PMID: 33233700 Free PMC article. Review.
-
Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1775-85. doi: 10.1007/s00259-008-0818-x. Epub 2008 May 15. Eur J Nucl Med Mol Imaging. 2008. PMID: 18481063 Clinical Trial.
-
PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer.Clin Nucl Med. 2015 Nov;40(11):e501-5. doi: 10.1097/RLU.0000000000000837. Clin Nucl Med. 2015. PMID: 26053713 Free PMC article.
-
Diagnostic management of pancreatic cancer.Cancers (Basel). 2011 Jan 31;3(1):494-509. doi: 10.3390/cancers3010494. Cancers (Basel). 2011. PMID: 24212626 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical